Role of Serum Vitamin D, Interleukin 13, and microRNA-135a in Hepatocellular Carcinoma and Treatment Failure in Egyptian HCV-Infected Patients Receiving Direct Antiviral Agents

Direct-acting antivirals (DAAs) are used for hepatitis C virus (HCV) treatment. However, treatment failure and hepatocellular carcinoma (HCC) development following treatment was reported. In this study, we assessed the role of serum vitamin D, interleukin 13 (IL-13), and microRNA-135a in the predict...

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Mohamed E. Ali, Hamada M. Halby, Mamdouh Yones Ali, Elham Ahmed Hassan, Mohamed A. El-Mokhtar, Ibrahim M. Sayed, Marwa M. Thabet, Magdy Fouad, Ahmed M. El-Ashmawy, Zainab Gaber Mahran
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	MDPI AG 2021-10-01
Seri Bilgileri:	Viruses
Konular:	HCV prognostic marker IL-13 vit D miRNA-135a HCC
Online Erişim:	https://www.mdpi.com/1999-4915/13/10/2008
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!